- Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux
Uddin Nazim et al, 2020, International Journal of Molecular Medicine CrossRef - Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells
LIN LI et al, 2016, Oncology Reports CrossRef - Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma
Ji-Yong Yoon et al, 2017, Oncotarget CrossRef - CSC‐3436 sensitizes triple negative breast cancer cells to TRAIL‐induced apoptosis through ROS‐mediated p38/CHOP/death receptor 5 signaling pathways
Chun‐Chen Huang et al, 2021, Environmental Toxicology CrossRef - Enhanced expression of death receptor 5 is responsible for increased cytotoxicity of theophylline in combination with recombinant human TRAIL in MDA-MB-231 breast cancer cells
Ranjana Pal et al, 2022, Journal of Cancer Research and Therapeutics CrossRef - Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up‐regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
Xinran Qiao et al, 2018, Cancer Communications CrossRef - Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells
Chao-Ming Hung et al, 2017, Journal of Agricultural and Food Chemistry CrossRef - Crescent-Like Lesions as an Early Signature of Nephropathy in a Rat Model of Prediabetes Induced by a Hypercaloric Diet
Sara Nunes et al, 2020, Nutrients CrossRef - Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells
Malaney C. Young et al, 2023, Natural Product Communications CrossRef - Isolation of eugenyl β-primeveroside from Camellia sasanqua and its anticancer activity in PC3 prostate cancer cells
Chun-Chieh Wang et al, 2016, Journal of Food and Drug Analysis CrossRef - TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies
Adel Naimi et al, 2018, Biomedicine & Pharmacotherapy CrossRef